Browse by Audience
MEMBER

Update Your Profile
Member Spotlights
Refer a Member: IASP Champions
Join a Special Interest Group (SIG)
Find a Chapter
Join Now

RESEARCHER

PAIN
PAIN Reports
Pain Research Forum
Papers of the Week
Webinars and Podcasts
Events

HEALTH CARE PROVIDER

Online Learning - PERC
Webinars & Podcasts
Curricula
Graduate Opportunities
Events

PATIENT & CAREGIVER

RELIEF News
Resources for Living with Pain
Global Alliance of Partners in Pain Advocacy (GAPPA)
Events

PARTNER

Support IASP
Sponsor an Event
Become a Partner

gy2022-1-3
I am a
IASP Logo
Home I AM A Search Login

Papers of the Week

Home / Publications / Pain Research Forum / Papers of the Week / [Galcanezumab for episodic and chronic cluster headache].

< BACK TO ARCHIVE


Papers: 23 Apr 2022 - 29 Apr 2022

PAIN TYPE:
Migraine/Headache


2022 Apr 27


Schmerz


http://www.ncbi.nlm.nih.gov/pubmed/35476143?dopt=Abstract

[Galcanezumab for episodic and chronic cluster headache].

Authors

[Galcanezumab for episodic and chronic cluster headache].
Pohl H, Holle-Lee D, Broicher SD, Schwerdtner I, Gantenbein AR, Gaul C
Schmerz. 2022 Apr 27.
PMID: 35476143.

Abstract

Cluster headache (CH) is a highly debilitating headache disorder characterized by frequent attacks of excruciating unilateral pain accompanied by cranial autonomic symptoms. Calcitonin gene-related peptide (CGRP) is implicated in the pathophysiology of CH.
Read This Paper